Patent details

EP3439662 Title: LIQUID FORMULATIONS OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE

Basic Information

Publication number:
EP3439662
PCT Application Number:
US2017025939
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP177182565
PCT Publication Number:
WO2017176751
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LIQUID FORMULATIONS OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE
French Title of Invention:
FORMULATIONS LIQUIDES DE (S)-N-(5-((R)-2-(2,5-DIFLUOROPHÉNYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE
German Title of Invention:
FLÜSSIGE FORMULIERUNGEN VON (S)-N-(5-((R)-2-(2,5-DIFLUORPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDIN-1-CARBOXAMID
SPC Number:

Dates

Filing date:
04/04/2017
Grant date:
24/07/2024
EP Publication Date:
13/02/2019
PCT Publication Date:
12/10/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/07/2024
EP B1 Publication Date:
24/07/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
04/04/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/07/2024
 
 

Name:
Loxo Oncology, Inc.
Address:
281 Tresser Boulevard 9th Floor, Stamford, Connecticut 06901, United States (US)

Agent

Name:
NOVAGRAAF BREVETS
From:
14/08/2024
Address:
BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
To:

Inventor

1

Name:
SMITH, Steven A.
Address:
United States (US)

2

Name:
REYNOLDS, Mark
Address:
United States (US)

Priority

1

Priority Number:
201662318041 P
Priority Date:
04/04/2016
Priority Country:
United States (US)

2

Priority Number:
201662323452 P
Priority Date:
15/04/2016
Priority Country:
United States (US)

3

Priority Number:
201662329561 P
Priority Date:
29/04/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/519; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202430
Publication date:
24/07/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/03/2025
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
16/08/2024 Outgoing Correspondence 1
14/08/2024 Power Of Attorney 1